Scientists in Italy say they have discovered that the grapes used to make some of the most popular red wines contain high levels of the sleep hormone melatonin.
Melatonin is naturally secreted by the pineal gland in the brain, especially at night. It tells the body when it is time to sleep.
The discovery of melatonin in grape skin could explain why so many of us hit the bottle in the evening to wind down after a day's hard slog. 'The melatonin content in wine could help regulate the circadian rhythm [sleep-wake patterns], just like the melatonin produced by the pineal gland in mammals,' says researcher Iriti Marcello at the University of Milan.
Until recently, melatonin was thought to be exclusively produced by mammals but has recently been discovered in plants. It is thought to have antioxidant properties. Iriti's study discovered high levels of melatonin in Nebbolo, Merlot, Cabernet Savignon, Sangiovesse and Croatina grape varieties.
Iriti's team have also shown that melatonin content can be enhanced in grapes by treating vines with a plant vaccine Benzothiadiazole.
Richard Wurtman of the brain and cognitive science department at MIT is unconvinced, however, and believes further research is needed to determine whether the compounds discovered are melatonin, or something very similar.
Citation: Journal of the Science of Food and Agriculture, DOI 10.1002/jsfa2537
Source: Society of Chemical Industry
Related stories:
Mounting evidence shows red wine antioxidant kills cancer
Rochester researchers showed for the first time that a natural antioxidant found in grape skins and red wine can help destroy pancreatic cancer cells by reaching to the cell's core energy source, or mitochondria, and crippling its function. The study is published in the March edition of the journal,
Advances in Experimental Medicine and Biology.
Many insomniacs turn to valerian and melatonin to help them sleep
A study published in the July 1st issue of the journal SLEEP finds that large segments of the U.S. population use valerian or melatonin to treat their insomnia.
MIT study confirms melatonin's value as sleep aid
A new study by MIT scientists and colleagues confirms that melatonin is an effective sleep aid for older insomniacs and others. Misuse of the hormone had led some to question its efficacy, but the latest work (published in the February issue of Sleep Medicine Reviews) could jump-start interest in the dietary supplement and help more people get a good night's sleep.
The first autism disease genes
The autistic disorder was first described, more than sixty years ago, by Dr. Leo Kanner of the Johns Hopkins Hospital (USA), who created the new label 'early infantile autism'. At the same time an Austrian scientist, Dr. Hans Asperger, described a milder form of the disorder that became known as Asperger Syndrome, characterised by higher cognitive abilities and more normal language function. Today, both disorders are classified in the continuum of 'Pervasive Developmental Disorders' (PDD), more often referred to as Autism Spectrum Disorders (ASD).
A therapy for baby boomers to sleep on
If you're over 55 and have spent more than a few sleepless nights, you're not alone -- insomnia affects about half of all people over 55 -- but you may also be at increased risk for physical and mental ailments.
Perfect Vision But Blind To Light
Mammals have two types of light-sensitive detectors in the retina. Known as rod and cone cells, they are both necessary to picture their environment. However, researchers at the Salk Institute for Biological Studies have found that eliminating a third sensor — cells expressing a photopigment called melanopsin that measures the intensity of incoming light —makes the circadian clock blind to light, yet leaves normal vision intact.
Use of bright lighting may improve dementia symptoms for elderly persons
The use of daytime bright lighting to improve the circadian rhythm of elderly persons was associated with modest improvement in symptoms of dementia, and the addition of the use of melatonin resulted in improved sleep, according to a study in the June 11 issue of JAMA.
Researchers identify gene that regulates glucose levels and increases risk for diabetes
Researchers at the University of Southern California (USC) have helped identify a genetic variant that regulates glucose levels and also increases the risk of type 2 diabetes. The results of the study were presented as an oral presentation on Saturday, June 7, at the American Diabetes Association 68th Scientific Sessions held in San Francisco.